A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF A NOVEL RECOMBINANT, HUMANISED, ANTI-INTERLEUKIN-13 MONOCLONAL ANTIBODY (RPC4046) IN PATIENTS WITH ACTIVE EOSINOPHILIC OESOPHAGITIS: RESULTS OF THE HEROES STUDY

Ikuo Hirano  1     Margaret H. Collins  2     Yudith Assouline-Dayan  3     Larry Evans  4     Sandeep Gupta  5     Alain Schoepfer     Michael Grimm     Heather Smith     Cindy-ann Tompkins     Amy Woo     Robert Peach     Paul A. Frohna     Sheila Gujrathi     Richard Aranda     Evan S Dellon    
1 Feinberg School of Medicine, Chicago, United States of America
2 University of Cincinnati, College of Medicine, Cincinnati, United States of America
3 Carver College of Medicine, Iowa City, United States of America
4 Grand Teton Research Group, Idaho Falls, United States of America
5 Indiana University School of Medicine, Indianapolis, Uni

Conference
UEG Week 2016

Citation
United European Gastroenterology Journal; 2016: 2 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at office@ueg.eu

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing